University of Kansas Medical Center
Mission Statement
At a Glance
0
Educational Resources Posted
4
Consortium News Stories Posted
1
Events Posted
1
Opportunities Posted
Coming Soon
Publications citing CTSA Program Grant
20
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Administrator
Education
KL2 Director
KL2 Administrator
TL1 Director
TL1 Administrator
Communications
Communications Representative
Enterprise Committees
Integration Across Lifespan Voting Member
Common Metrics
Primary CM Contact
Additional CM Contacts
AmandaBrinkerDeputy Director for The Institute for Advancing Medical Innovation
MarioCastroDirector, Frontiers: University of Kansas Clinical and Translational Science Institute
MaryHindleDivision Director, Research Communications & Education
KimKimminauProfessor and Associate Director, Frontiers: University of Kansas Clinical and Translational Science Institute
Events
Radical Changes in Healthcare Delivery Due to COVID-19: a KC QVIC Forum
The Kansas City Quality and Value Innovation Consortium (KC QVIC) is hosting an online forum on Thursday, June 4, for healthcare leaders from across the metro to discuss how healthcare has changed due to the COVID-19 pandemic.
Opportunities
Frontiers Project Manager
Frontiers: University of Kansas Clinical and Translational Science Institute is looking for a Project Manager to help organize and submit our renewal application and become an integral part of the team. This person will work with a senior team of researchers and clinicians and will be responsible
Posters
Conducting a COVID-19 Vaccine Trial Using CTSA Resources: Lessons Learned
AZD1222 is being developed for the prevention of COVID-19. AZD1222 is a recombinant replication-defective chimpanzee adenovirus expressing the SARS-CoV-2 S surface glycoprotein, commonly known as the “Oxford vaccine” or as “ChAdOx.” We describe a “scale up” approach utilizing CTSA resources to
